Product Pipeline

Delivering therapies for patients with unmet medical needs

Santaris Pharma A/S Drug Discovery Engine has leveraged the LNA Drug Platform to create a robust pipeline of drugs for a range of diseases including infectious and inflammatory diseases, metabolic disorders, cancer and rare genetic disorders. Leveraging its Drug Discovery Engine, Santaris Pharma A/S has been able to create an attractive in-house pipeline of innovative LNA-based drugs, with the ability to move from target selection to clinical trials in less than 18 months.